← 產業報告目錄
US Artificial Intelligence (AI) in Mental Health Market Research Report Data Analysis By Component (hardware, software solutions and services), by Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression, Anxiety, and Others), by Application (Clinical Diagnosis and Treatment, Patient Engagement And Education, Remote Patient Monitoring, and Others), by Technology (Natural Language Processing (NLP), Machine Learning (ML), Deep Learning, Others), by End User (Healthcare Providers, Corporate Organizations, and Others) -Forecast to 2032
授權報價
| Single User Price | $2,950 USD |
| Multi User Licence (up to 10 users) | $3,950 USD |
| Enterprisewide Price (Global Site License) | $5,250 USD |
報告摘要
US Artificial Intelligence (AI) in Mental Health Market Research Report Data Analysis By Component (hardware, software solutions and services), by Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression, Anxiety, and Others), by Application (Clinical Diagnosis and Treatment, Patient Engagement And Education, Remote Patient Monitoring, and Others), by Technology (Natural Language Processing (NLP), Machine Learning (ML), Deep Learning, Others), by End User (Healthcare Providers, Corporate Organizations, and Others) -Forecast to 2032
Market Overview
US Artificial Intelligence (AI) in Mental Health market is anticipated to exhibit a significant CAGR of 23.12% during the review period. AI in mental health refers to the utilization of artificial intelligence (AI) technologies such as machine learning, natural language processing, and data analytics to assist in the diagnosis, treatment, and management of mental health disorders. This involves the development and implementation o, f AI-powered tools and applications to augment traditional methods of mental health care delivery.
The increasing incidences of mental illnesses across the US and the shortage of mental health professionals are the major factors driving the growth of global AI in the mental health market. However, the high cost associated with AI in mental health services and products is expected to hamper the growth of the global market. Nevertheless, increasing funding & investment in AI in mental health across the US is anticipated to create lucrative opportunities for the market.
Market Segmentation
Based on the component, the US Artificial Intelligence (AI) in Mental Health Market has been segmented into hardware, software solutions and services.
Based on disorder, the market has been segmented into schizophrenia, alcohol use disorders, bipolar disorder, depression, anxiety, and others.
Based on application, the market has been segmented into clinical diagnosis and treatment, patient engagement and education, remote patient monitoring, and others.
Based on technology, the market has been segmented into Natural Language Processing (NLP), Machine Learning (ML), Deep Learning, Others.
Based on end users, the market has been segmented into healthcare providers, corporate organizations, and others.
Major Players
The key players operating in the the US Artificial Intelligence (AI) in Mental Health Market are Talkspace Inc., Wysa Ltd, Lyra Health, Inc., Headspace Health, Woebot Health, Muse (Interaxon), TELUS, Cass, and The TouchPoint Solution.
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 14
2 MARKET INTRODUCTION 16
2.1 DEFINITION 16
2.2 SCOPE OF THE STUDY 16
2.3 RESEARCH OBJECTIVE 16
2.4 MARKET STRUCTURE 17
3 RESEARCH METHODOLOGY 18
3.1 OVERVIEW 18
3.2 DATA FLOW 20
3.2.1 DATA MINING PROCESS 20
3.3 PURCHASED DATABASE: 21
3.4 SECONDARY SOURCES: 22
3.4.1 SECONDARY RESEARCH DATA FLOW: 23
3.5 PRIMARY RESEARCH: 24
3.5.1 PRIMARY RESEARCH DATA FLOW: 25
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 26
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 27
3.6.1 REVENUE ANALYSIS APPROACH 27
3.7 DATA FORECASTING 28
3.7.1 DATA FORECASTING TYPE 28
3.8 DATA MODELING 29
3.8.1 MICROECONOMIC FACTOR ANALYSIS: 29
3.8.2 DATA MODELING: 30
3.9 TEAMS AND ANALYST CONTRIBUTION 32
4 MARKET DYNAMICS 34
4.1 INTRODUCTION 34
4.2 DRIVERS 35
4.2.1 INCREASING INCIDENCES OF MENTAL ILLNESSES ACROSS U.S. 35
4.2.2 SHORTAGE OF MENTAL HEALTH PROFESSIONALS 35
4.3 RESTRAINTS 36
4.3.1 HIGH COST ASSOCIATED WITH AI IN MENTAL HEALTH SERVICES AND PRODUCTS 36
4.4 OPPORTUNITY 37
4.4.1 INCREASING FUNDING & INVESTMENT FOR AI IN MENTAL HEALTH ACROSS THE US 37
5 MARKET FACTOR ANALYSIS 38
5.1 PORTER'S FIVE FORCES MODEL 38
5.1.1 THREAT OF NEW ENTRANTS 38
5.1.2 BARGAINING POWER OF SUPPLIERS 39
5.1.3 THREAT OF SUBSTITUTES 39
5.1.4 BARGAINING POWER OF BUYERS 39
5.1.5 INTENSITY OF RIVALRY 39
5.2 IMPACT OF COVID-19 ON THE US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET 40
5.3 QUALITATIVE OVERVIEW ON CURRENT AND EMERGING AI TECHNOLOGIES AND APPLICATIONS IN THE MENTAL HEALTH SECTOR WITHIN THE US 40
5.4 QUALITATIVE OVERVIEW ON THE CURRENT LANDSCAPE, INCLUDING TECHNOLOGICAL ADVANCEMENTS, WHAT IS BEING ADOPTED, IMPLICATIONS, AND GAPS IN THE US MARKET 41
5.5 TRENDS AND INNOVATIONS IN THE US ARTIFICIAL INTELLIGENCE (AI) IN THE MENTAL HEALTH MARKET 42
5.6 QUALITATIVE OVERVIEW ON SUCCESSFUL CASE STUDIES AND CHALLENGES 42
5.7 QUALITATIVE OVERVIEW ON ADOPTION OF AI TECHNOLOGIES IN MENTAL HEALTH SERVICES ACROSS THE US 43
5.8 REGULATORY LANDSCAPE FOR US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKE MARKET 45
5.9 LIST OF MAJOR KEY PLAYERS AND QUALITATIVE INFORMATION ON FUNDING SOURCES 46
5.9.1 LIST OF MAJOR PLAYERS 46
5.9.2 QUALITATIVE INFORMATION ON FUNDING SOURCES 46
5.10 OVERVIEW: IMPACT OF AI TOOLS ON PATIENT OUTCOMES, CLINICIAN WORKLOAD, AND COST-EFFECTIVENESS 48
5.11 RECOMMENDATIONS FOR OPTIMIZING AI INTEGRATION IN THE MENTAL HEALTH MARKET 50
6 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT 52
6.1 OVERVIEW 52
7 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER 55
7.1 OVERVIEW 55
8 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION 58
8.1 OVERVIEW 58
9 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY 61
9.1 OVERVIEW 61
10 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY END USER 64
10.1 OVERVIEW 64
11 GLOBAL OVERVIEW 67
11.1 GLOBAL AND EUROPEAN TRENDS, WITH ATTENTION TO EUROPEAN DEVELOPMENTS FOR ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET 67
11.1.1 COMPARISON OF TRENDS BETWEEN EUROPEAN AND GLOBAL MARKETS 68
11.2 QUALITATIVE INSIGHTS INTO AI APPLICATIONS IN MENTAL HEALTH AND PSYCHOLOGY IN EUROPE AND OTHER REGIONS 69
11.3 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY REGION (USD MILLION) 71
11.4 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT (USD MILLION) 72
11.5 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER 74
11.6 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION 75
11.7 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY 77
11.8 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY END USER 78
11.8.1 HEALTHCARE PROVIDERS 79
12 COMPETITIVE LANDSCAPE 81
12.1 INTRODUCTION 81
12.2 MARKET SHARE ANALYSIS, 2022 81
12.3 COMPETITOR DASHBOARD 82
12.4 PUBLIC PLAYERS STOCK SUMMARY 83
12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 83
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 83
12.6.1 PRODUCT LAUNCH/SERVICE LAUNCH 83
12.6.2 COLLABORATION 84
12.6.3 PARTNERSHIP 84
12.6.4 MERGER 84
13 COMPANY PROFILES 85
13.1 TALKSPACE INC 85
13.1.1 COMPANY OVERVIEW 85
13.1.2 FINANCIAL OVERVIEW 86
13.1.3 SERVICE OFFERED 86
13.1.4 KEY DEVELOPMENTS 87
13.1.5 SWOT ANALYSIS 87
13.1.6 KEY STRATEGIES 87
13.2 WOEBOT HEALTH 88
13.2.1 COMPANY OVERVIEW 88
13.2.2 FINANCIAL OVERVIEW 88
13.2.3 PRODUCTS OFFERED 88
13.2.4 KEY DEVELOPMENTS 89
13.2.5 SWOT ANALYSIS 89
13.2.6 KEY STRATEGIES 89
13.3 LYRA HEALTH, INC 90
13.3.1 COMPANY OVERVIEW 90
13.3.2 FINANCIAL OVERVIEW 90
13.3.3 PRODUCTS/SERVICS OFFERED 91
13.3.4 KEY DEVELOPMENTS 91
13.3.5 KEY STRATEGIES 91
13.4 MUSE 92
13.4.1 COMPANY OVERVIEW 92
13.4.2 FINANCIAL OVERVIEW 92
13.4.3 PRODUCTS OFFERED 93
13.4.4 KEY DEVELOPMENTS 93
13.4.5 KEY STRATEGIES 93
13.5 TELUS 94
13.5.1 COMPANY OVERVIEW 94
13.5.2 FINANCIAL OVERVIEW 94
13.5.3 PRODUCTS OFFERED 95
13.5.4 KEY DEVELOPMENTS 95
13.5.5 KEY STRATEGIES 95
13.6 WYSA LTD 96
13.6.1 COMPANY OVERVIEW 96
13.6.2 FINANCIAL OVERVIEW 96
13.6.3 PRODUCTS OFFERED 96
13.6.4 KEY DEVELOPMENTS 97
13.6.5 SWOT ANALYSIS 97
13.6.6 KEY STRATEGIES 97
13.7 HEADSPACE HEALTH 98
13.7.1 COMPANY OVERVIEW 98
13.7.2 FINANCIAL OVERVIEW 98
13.7.3 SERVICES OFFERED 99
13.7.4 KEY DEVELOPMENTS 99
13.7.5 SWOT ANALYSIS 100
13.7.6 KEY STRATEGIES 100
13.8 CASS 101
13.8.1 COMPANY OVERVIEW 101
13.8.2 FINANCIAL OVERVIEW 101
13.8.3 PRODUCTS OFFERED 101
13.8.4 KEY DEVELOPMENTS 102
13.8.5 SWOT ANALYSIS 102
13.8.6 KEY STRATEGIES 103
13.9 OURA HEALTH OY 103
13.9.1 COMPANY OVERVIEW 103
13.9.2 FINANCIAL OVERVIEW 103
13.9.3 PRODUCTS OFFERED 103
13.9.4 KEY DEVELOPMENTS 104
13.9.5 KEY STRATEGIES 104
13.10 THE TOUCHPOINT SOLUTION 105
13.10.1 COMPANY OVERVIEW 105
13.10.2 FINANCIAL OVERVIEW 105
13.10.3 PRODUCT OFFERED 105
13.10.4 KEY DEVELOPMENTS 105
13.10.5 KEY STRATEGIES 106
14 APPENDIX 107
14.1 MARKET SIZE 107
14.2 CAGR 107
14.3 MARKET DYNAMICS 107
14.4 MARKET FACTOR ANALYSIS 108
14.5 SEGMENTS 109
14.5.1 COMPONENT 109
14.5.2 DISORDER 109
14.5.3 APPLICATION 110
14.5.4 TECHNOLOGY 110
14.5.5 END USER 111
14.5.6 COMPANY PROFILES 111
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 30
TABLE 2 REGULATORY LANDSCAPE BY US 45
TABLE 3 LIST OF MAJOR PLAYERS 46
TABLE 4 LIST FUNDING GRANTED/APPROVED RECENTLY 48
TABLE 5 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT, 2019-2032 (USD MILLION) 53
TABLE 6 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER, 2019-2032 (USD MILLION) 56
TABLE 7 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 59
TABLE 8 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 62
TABLE 9 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION) 65
TABLE 10 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, FOR HEALTHCARE PROVIDERS, BY TYPE, 2019-2032 (USD MILLION) 66
TABLE 11 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT, 2019-2032 (USD MILLION) 71
TABLE 12 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT, 2019-2032 (USD MILLION) 73
TABLE 13 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER, 2019-2032 (USD MILLION) 74
TABLE 14 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 76
TABLE 15 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY, 2022 & 2032 (USD MILLION) 77
TABLE 16 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION) 79
TABLE 17 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, FOR HEALTHCARE PROVIDERS, BY TYPE, 2019-2032 (USD MILLION) 79
TABLE 18 PUBLIC PLAYERS STOCK SUMMARY 83
TABLE 19 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 83
TABLE 20 PRODUCT LAUNCH/SERVICE LAUNCH 83
TABLE 21 COLLABORATION 84
TABLE 22 PARTNERSHIP 84
TABLE 23 MERGER 84
TABLE 24 TALKSPACE INC: SERVICE OFFERED 86
TABLE 25 WOEBOT HEALTH: PRODUCT OFFERED 88
TABLE 26 LYRA HEALTH, INC: PRODUCT/SERVICES OFFERED 91
TABLE 27 LYRA HEALTH, INC: KEY DEVELOPMENTS 91
TABLE 28 MUSE: PRODUCT OFFERED 93
TABLE 29 TELUS: PRODUCT OFFERED 95
TABLE 30 WYSA LTD: PRODUCT OFFERED 96
TABLE 31 WYSA LTD: KEY DEVELOPMENTS 97
TABLE 32 HEADSPACE HEALTH: SERVICE OFFERED 99
TABLE 33 HEADSPACE HEALTH: KEY DEVELOPMENTS 99
TABLE 34 CASS: PRODCUTS OFFERED 101
TABLE 35 OURA HEALTH OY.: PRODCUTS OFFERED 103
TABLE 36 THE TOUCHPOINT SOLUTION: PRODUCT OFFERED 105
LIST OF FIGURES
FIGURE 1 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET: STRUCTURE 17
FIGURE 2 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 34
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 36
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 37
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET 38
FIGURE 6 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, COMPONENT SEGMENT ATTRACTIVENESS, 2019 & 2032 (USD MILLION) 52
FIGURE 7 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT 2022 & 2032 (USD MILLION) 53
FIGURE 8 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT, 2022 (% SHARE) 54
FIGURE 9 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER, SEGMENT ATTARCTIVENESS ANALYSIS 55
FIGURE 10 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER 2022 & 2032 (USD MILLION) 56
FIGURE 11 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER, 2022 (% SHARE) 57
FIGURE 12 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION, SEGMENT ATTARCTIVENESS ANALYSIS 58
FIGURE 13 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION 2022 & 2032 (USD MILLION) 59
FIGURE 14 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION, 2022 (% SHARE) 60
FIGURE 15 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY, SEGMENT ATTARCTIVENESS ANALYSIS 61
FIGURE 16 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY, 2022 & 2032 (USD MILLION) 62
FIGURE 17 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY, 2022 (% SHARE) 63
FIGURE 18 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY END USER, SEGMENT ATTARCTIVENESS ANALYSIS 64
FIGURE 19 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY END USER, 2022 & 2032 (USD MILLION) 65
FIGURE 20 US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY END USER, 2022 (% SHARE) 66
FIGURE 21 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY REGION 2022 & 2032 (USD MILLION) 71
FIGURE 22 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY REGION, 2022 (% SHARE) 72
FIGURE 23 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT 2022 & 2032 (USD MILLION) 72
FIGURE 24 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY COMPONENT, 2022 (% SHARE) 73
FIGURE 25 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER 2022 & 2032 (USD MILLION) 74
FIGURE 26 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY DISORDER, 2022 (% SHARE) 75
FIGURE 27 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION) 75
FIGURE 28 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY APPLICATION, 2022 (% SHARE) 76
FIGURE 29 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY, 2022 & 2032 (USD MILLION) 77
FIGURE 30 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY TECHNOLOGY, 2022 (% SHARE) 78
FIGURE 31 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, , BY END USER, 2022 & 2032 (USD MILLION) 78
FIGURE 32 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET, BY END USER, 2022 (% SHARE) 79
FIGURE 33 ARTIFICIAL INTELLIGENCE (AI) IN MENTAL MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 81
FIGURE 34 COMPETITOR DASHBOARD: US ARTIFICIAL INTELLIGENCE (AI) IN MENTAL HEALTH MARKET 82
FIGURE 35 TALKSPACE INC: FINANCIAL OVERVIEW SNAPSHOT 86
FIGURE 36 TALKSPACE INC.: SWOT ANALYSIS 87
FIGURE 37 WOEBOT HEALTH.: SWOT ANALYSIS 89
FIGURE 38 WYSA LTD: SWOT ANALYSIS 97
FIGURE 39 HEADSPACE HEALTH: SWOT ANALYSIS 100
FIGURE 40 CASS: SWOT ANALYSIS 102
提及公司
Talkspace Inc.Wysa LtdLyra HealthInc.Headspace HealthWoebot HealthMuse (Interaxon)TELUSCassand The TouchPoint Solution.
同分類最新報告（醫療與生命科學）
查看醫療與生命科學全部報告 →
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們